Not Signed In - Candesartan therapy can reduce the risk of diabetes in heart failure patients
Sun, 10 Jul 2005 08:00 PM EST
... Candesartan is the first angiotensin receptor blocker (ARB) shown to reduce the risk of diabetes in heart failure patients compared to placebo, in new study analysis - A reduction in the risk of developing diabetes has been shown in heart failure patients on candesartan cilexetil ("candesartan") therapy... click link for more info. ...
Related Topics
- Congestive Heart Failure
- Risk Factors
- Coronary Heart Disease
- Heart Disease
- Candesartan
- Heart Diseases
- Diabetes - Type 2
- Coronary Disease
- Kidney Failure
- Increased risk of heart attack from untreated diabetes and high cholesterol
- Chelation therapy
- Genes and Gene Therapy
- Heart Bypass Surgery
- Diabetes - Type 1
- Heart Attack
- Smoking Cessation and Continued Risk in Cancer Patients
- Diabetes Insipidus
- Color Therapy
- Music therapy
- Gestational Diabetes
email this page
print this page
bookmark this page
feedback on this page
